NO20001497L - Ekspresjon av endogene gener ved ikke-homolog rekombinasjon av en vektorkonstrukt med cellulært DNA - Google Patents
Ekspresjon av endogene gener ved ikke-homolog rekombinasjon av en vektorkonstrukt med cellulært DNAInfo
- Publication number
- NO20001497L NO20001497L NO20001497A NO20001497A NO20001497L NO 20001497 L NO20001497 L NO 20001497L NO 20001497 A NO20001497 A NO 20001497A NO 20001497 A NO20001497 A NO 20001497A NO 20001497 L NO20001497 L NO 20001497L
- Authority
- NO
- Norway
- Prior art keywords
- expression
- gene
- genes
- methods
- nucleic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94122397A | 1997-09-26 | 1997-09-26 | |
US15964398A | 1998-09-24 | 1998-09-24 | |
PCT/US1998/020094 WO1999015650A1 (en) | 1997-09-26 | 1998-09-25 | Expression of endogenous genes by non-homologous recombination of a vector construct with cellular dna |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20001497D0 NO20001497D0 (no) | 2000-03-22 |
NO20001497L true NO20001497L (no) | 2000-05-25 |
Family
ID=26856150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20001497A NO20001497L (no) | 1997-09-26 | 2000-03-22 | Ekspresjon av endogene gener ved ikke-homolog rekombinasjon av en vektorkonstrukt med cellulært DNA |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1017803B1 (no) |
JP (1) | JP5377806B2 (no) |
KR (1) | KR20010024296A (no) |
CN (1) | CN100582230C (no) |
AT (1) | ATE471373T1 (no) |
AU (1) | AU750025B2 (no) |
BR (1) | BR9812540A (no) |
CA (1) | CA2304642C (no) |
DE (1) | DE69841723D1 (no) |
DK (1) | DK1017803T3 (no) |
HK (1) | HK1027375A1 (no) |
IL (2) | IL135242A0 (no) |
NO (1) | NO20001497L (no) |
NZ (1) | NZ504185A (no) |
WO (1) | WO1999015650A1 (no) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6897066B1 (en) | 1997-09-26 | 2005-05-24 | Athersys, Inc. | Compositions and methods for non-targeted activation of endogenous genes |
US6740503B1 (en) | 1997-09-26 | 2004-05-25 | Athersys, Inc. | Compositions and methods for non-targeted activation of endogenous genes |
JP2004501601A (ja) * | 1999-02-19 | 2004-01-22 | アサーシス,インコーポレイテッド | 標的化によらない内在性遺伝子の活性化組成物および活性化方法 |
JP2003527833A (ja) | 1999-10-14 | 2003-09-24 | クロンテック・ラボラトリーズ・インコーポレーテッド | 花虫類に由来する発色団/蛍光体、およびそれらの使用法 |
PT2077279E (pt) | 2000-06-28 | 2012-09-14 | Amgen Inc | Moléculas do receptor de linfopoietina estromal tímica e suas utilizações |
GB0018876D0 (en) * | 2000-08-01 | 2000-09-20 | Applied Research Systems | Method of producing polypeptides |
EP1352060A2 (en) * | 2000-10-30 | 2003-10-15 | Novozymes Biotech, Inc. | Methods for expressing endogenous genes by restriction enzyme mediated integration |
DK1451295T3 (en) | 2001-11-02 | 2015-07-06 | Athersys Inc | METHODS FOR MUTATION OF GENES IN CELLS AND ANIMALS USING THE INSERTION MUTAGENES. |
AU2002357322A1 (en) | 2001-12-19 | 2003-07-09 | The University Of Chicago | Rapidly maturing fluorescent proteins and methods for using the same |
US7662924B2 (en) | 2002-02-22 | 2010-02-16 | The Board Of Trustees Of The University Of Illinois | Beta chain-associated regulator of apoptosis |
WO2004028243A2 (en) | 2002-08-21 | 2004-04-08 | Revivicor, Inc. | Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase |
US9453251B2 (en) | 2002-10-08 | 2016-09-27 | Pfenex Inc. | Expression of mammalian proteins in Pseudomonas fluorescens |
US8021833B2 (en) | 2003-02-12 | 2011-09-20 | Functional Genetics, Inc. | Method for reducing HIV viral budding by administering a VPS28-specfic antibody that disrupts Gag-TSG101-VPS28 binding interactions |
US11311574B2 (en) | 2003-08-08 | 2022-04-26 | Sangamo Therapeutics, Inc. | Methods and compositions for targeted cleavage and recombination |
US7888121B2 (en) | 2003-08-08 | 2011-02-15 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
US8409861B2 (en) | 2003-08-08 | 2013-04-02 | Sangamo Biosciences, Inc. | Targeted deletion of cellular DNA sequences |
JP2007529278A (ja) | 2004-03-17 | 2007-10-25 | レビビコア, インコーポレイテッド | 機能的α1,3ガラクトシルトランスフェラーゼを欠く動物に由来する組織生成物 |
EP1732944B1 (en) | 2004-04-07 | 2012-09-05 | The University of Chicago | Monomeric red fluorescent proteins |
CA2574953A1 (en) | 2004-07-26 | 2006-02-09 | Dow Global Technolgies Inc. | Process for improved protein expression by strain engineering |
CA2958259C (en) | 2004-10-22 | 2020-06-30 | Revivicor, Inc. | Ungulates with genetically modified immune systems |
PA8660701A1 (es) | 2005-02-04 | 2006-09-22 | Pfizer Prod Inc | Agonistas de pyy y sus usos |
ES2772674T3 (es) | 2005-05-12 | 2020-07-08 | Zymogenetics Inc | Composiciones y métodos para modular respuestas inmunitarias |
AU2006292827B2 (en) | 2005-08-09 | 2013-02-14 | Revivicor, Inc. | Transgenic ungulates expressing CTLA4-IG and uses thereof |
WO2007053732A2 (en) | 2005-11-01 | 2007-05-10 | Mayo Foundation For Medical Education And Research | Promoter polymorphisms of the blys gene and use in diagnostic methods |
US8014957B2 (en) | 2005-12-15 | 2011-09-06 | Fred Hutchinson Cancer Research Center | Genes associated with progression and response in chronic myeloid leukemia and uses thereof |
EP2046826B1 (en) | 2006-07-24 | 2011-09-14 | Biorexis Pharmaceutical Corporation | Exendin fusion proteins |
CN101688213A (zh) | 2007-04-27 | 2010-03-31 | 陶氏环球技术公司 | 用于快速筛选微生物宿主以鉴定某些在表达异源蛋白质方面具有改善的产量和/或质量的菌株的方法 |
US9580719B2 (en) | 2007-04-27 | 2017-02-28 | Pfenex, Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
WO2009059305A2 (en) | 2007-11-01 | 2009-05-07 | The University Of Chicago | Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation |
US8003325B2 (en) | 2007-11-30 | 2011-08-23 | Mayo Foundation For Medical Education And Research | Polymorphisms of the BLyS gene and use in diagnostic methods |
US8883739B2 (en) | 2010-01-19 | 2014-11-11 | The Trustees Of Columbia University In The City Of New York | Osteocalcin as a treatment for male reproductive disorders |
CN102669057B (zh) * | 2011-03-18 | 2014-11-26 | 上海南方模式生物科技发展有限公司 | 一种调控动物内源基因表达的遗传修饰方法 |
KR101948248B1 (ko) * | 2011-11-18 | 2019-02-14 | 한국생명공학연구원 | 단백질 발현 미세 조절방법 |
US10052364B2 (en) | 2013-03-15 | 2018-08-21 | The Trustees Of Columbia University In The City Of New York | Osteocalcin as a treatment for cognitive disorders |
US9957515B2 (en) | 2013-03-15 | 2018-05-01 | Cibus Us Llc | Methods and compositions for targeted gene modification |
CN106455514A (zh) * | 2014-03-14 | 2017-02-22 | 希博斯美国有限公司 | 采用寡核苷酸介导的基因修复提高靶向基因修饰的效率的方法和组合物 |
US11191811B2 (en) | 2014-11-19 | 2021-12-07 | The Trustees Of Columbia University In The City Of New York | Osteocalcin as a treatment for frailty associated with aging |
JP2021524230A (ja) * | 2018-05-15 | 2021-09-13 | デューク ユニバーシティ | アッカーマンシア種の遺伝子操作のためのシステムおよび方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5024939A (en) * | 1987-07-09 | 1991-06-18 | Genentech, Inc. | Transient expression system for producing recombinant protein |
EP0747485B1 (en) * | 1989-11-06 | 1998-12-02 | Cell Genesys, Inc. | Production of proteins using homologous recombination |
US5204939A (en) * | 1989-12-14 | 1993-04-20 | Fujitsu Limited | Rule base processing system and rule evaluation control method therein |
US5272071A (en) * | 1989-12-22 | 1993-12-21 | Applied Research Systems Ars Holding N.V. | Method for the modification of the expression characteristics of an endogenous gene of a given cell line |
US5641670A (en) * | 1991-11-05 | 1997-06-24 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
US6270989B1 (en) * | 1991-11-05 | 2001-08-07 | Transkaryotic Therapies, Inc. | Protein production and delivery |
US5561053A (en) * | 1994-08-05 | 1996-10-01 | Genentech, Inc. | Method for selecting high-expressing host cells |
JP2004501601A (ja) * | 1999-02-19 | 2004-01-22 | アサーシス,インコーポレイテッド | 標的化によらない内在性遺伝子の活性化組成物および活性化方法 |
-
1998
- 1998-09-25 WO PCT/US1998/020094 patent/WO1999015650A1/en not_active Application Discontinuation
- 1998-09-25 EP EP98949508A patent/EP1017803B1/en not_active Expired - Lifetime
- 1998-09-25 AT AT98949508T patent/ATE471373T1/de not_active IP Right Cessation
- 1998-09-25 CA CA2304642A patent/CA2304642C/en not_active Expired - Lifetime
- 1998-09-25 NZ NZ504185A patent/NZ504185A/xx unknown
- 1998-09-25 KR KR1020007003195A patent/KR20010024296A/ko not_active Application Discontinuation
- 1998-09-25 CN CN98811571A patent/CN100582230C/zh not_active Expired - Lifetime
- 1998-09-25 AU AU95816/98A patent/AU750025B2/en not_active Expired
- 1998-09-25 DE DE69841723T patent/DE69841723D1/de not_active Expired - Lifetime
- 1998-09-25 DK DK98949508.0T patent/DK1017803T3/da active
- 1998-09-25 BR BR9812540-0A patent/BR9812540A/pt not_active IP Right Cessation
- 1998-09-25 JP JP2000512942A patent/JP5377806B2/ja not_active Expired - Lifetime
- 1998-09-25 IL IL13524298A patent/IL135242A0/xx unknown
-
2000
- 2000-03-22 NO NO20001497A patent/NO20001497L/no not_active Application Discontinuation
- 2000-03-23 IL IL135242A patent/IL135242A/en not_active IP Right Cessation
- 2000-10-04 HK HK00106276.2A patent/HK1027375A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1017803B1 (en) | 2010-06-16 |
NZ504185A (en) | 2003-02-28 |
CN1280615A (zh) | 2001-01-17 |
HK1027375A1 (en) | 2001-01-12 |
CN100582230C (zh) | 2010-01-20 |
CA2304642C (en) | 2014-11-18 |
EP1017803A4 (en) | 2002-01-09 |
ATE471373T1 (de) | 2010-07-15 |
WO1999015650A1 (en) | 1999-04-01 |
CA2304642A1 (en) | 1999-04-01 |
DK1017803T3 (da) | 2010-08-23 |
WO1999015650A9 (en) | 2000-09-08 |
NO20001497D0 (no) | 2000-03-22 |
EP1017803A1 (en) | 2000-07-12 |
DE69841723D1 (de) | 2010-07-29 |
KR20010024296A (ko) | 2001-03-26 |
JP2003535564A (ja) | 2003-12-02 |
IL135242A0 (en) | 2001-05-20 |
AU9581698A (en) | 1999-04-12 |
BR9812540A (pt) | 2001-12-26 |
IL135242A (en) | 2011-06-30 |
JP5377806B2 (ja) | 2013-12-25 |
AU750025B2 (en) | 2002-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20001497L (no) | Ekspresjon av endogene gener ved ikke-homolog rekombinasjon av en vektorkonstrukt med cellulært DNA | |
Lutz et al. | Alternative mRNA polyadenylation in eukaryotes: an effective regulator of gene expression | |
Hatfield et al. | How selenium has altered our understanding of the genetic code | |
Bogan et al. | Initiation of eukaryotic DNA replication: conservative or liberal? | |
Janda et al. | Brome mosaic virus RNA replication protein 1a dramatically increases in vivo stability but not translation of viral genomic RNA3 | |
Prévôt et al. | Characterization of a novel RNA‐binding region of eIF4GI critical for ribosomal scanning | |
SG141233A1 (en) | Control of gene expression | |
WO2000049162A8 (en) | Compositions and methods for non-targeted activation of endogenous genes | |
MX9606476A (es) | Inhibicion citoplasmica de expresion de genes. | |
WO1999036516A3 (en) | Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host | |
AU7599500A (en) | Novel gl50 molecules and uses therefor | |
Krauskopf et al. | Rap1 protein regulates telomere turnover in yeast | |
Cioffi et al. | An IgH Enhancer That Drives Transcription through Basic Helix-Loop-Helix and Oct Transcription Factor Binding Motifs: FUNCTIONAL ANALYSIS OF THE Eµ3′ ENHANCER OF THE CATFISH | |
AU2002320301A1 (en) | Novel pgc-1 isoforms and uses therefor | |
Wong et al. | A single point mutation at the 3′-untranslated region of Ran mRNA leads to profound changes in lipopolysaccharide endotoxin-mediated responses | |
Borovsky et al. | Juvenile hormone affects the splicing of Culex quinquefasciatus early trypsin messenger RNA | |
DE60142356D1 (de) | 18480 humane proteinkinasemoleküle und ihre verwendungen | |
DE60130465D1 (de) | Mutierte muskelspezifische enhancer | |
WO2001092495A3 (en) | A human lysyl ixodase (47765) and uses thereof | |
WO2001066765A3 (en) | 26583, a serine/threonine phosphatase and uses thereof | |
Morris | Fluorescence activated cell sorting of transiently transfected As4. 1 cells shows renin enhancer directs on/off switching of renin promoter in vitro | |
Sharma et al. | Transcriptional silencing of a tRNA1Gly copy from within a multigene family is modulated by distal cis elements | |
WO2002006485A3 (en) | 47885, a novel human ubiquitin-activating enzyme and uses therefor | |
Pavlova et al. | The structure and evolution of the MaSMC4 gene of common vole Microtus arvalis (Arvicolidae, Rodentia) | |
AU2001285204A1 (en) | Atcr-1, a human acyltransferase and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |